MRPS23 and nasopharyngeal carcinoma: Notably, pharmacological inhibition of proteasomal activity with MG132 markedly attenuated the reduction in β-catenin levels induced by dual knockdown of MRPS7 and MRPS23 in NPC cells (Fig. 5E).